Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company,
today announced fourth quarter and full year fiscal 2024 financial
results for the period ended January 31, 2024.
- Revenue for the fourth quarter of
fiscal 2024 was $51.6 million, down 38.1% from $83.3 million in the
same period in fiscal 2023. For the fiscal year ended January 31,
2024, revenue was $226.5 million, down 32.9% from $337.6 million
for the fiscal year ended January 31, 2023.
- Gross margin under U.S. generally
accepted accounting principles (GAAP) for the fourth quarter of
fiscal 2024 was 59.8%, compared with 59.6% for the same period in
fiscal 2023. For the fiscal year ended January 31, 2024, GAAP gross
margin was 60.4%, compared with 61.9% for the fiscal year ended
January 31, 2023.
- GAAP net loss for the fourth
quarter of fiscal 2024 was $60.6 million, or loss per diluted
ordinary share of $1.50, compared with a GAAP net loss of $11.1
million, or loss per diluted ordinary share of $0.29, for the same
period in fiscal 2023. GAAP net loss for the fiscal year ended
January 31, 2024 was $169.4 million, or loss per diluted ordinary
share of $4.25. This compares with GAAP net loss of $65.4 million,
or loss per diluted ordinary share of $1.70, for the fiscal year
ended January 31, 2023. For the fourth quarter and full fiscal year
ended January 31, 2024, GAAP net loss included a one-time income
tax charge of $22.7 million establishing a valuation allowance on
certain U.S. deferred tax assets that are deemed
more-likely-than-not to be unrealizable in the foreseeable
future.
Financial results on a non-GAAP basis for the fourth quarter and
full year fiscal 2024 are as follows:
- Gross margin on a non-GAAP basis
for the fourth quarter of fiscal 2024 was 62.5%, compared with
63.5% for the same period in fiscal 2023. For the fiscal year ended
January 31, 2024, non-GAAP gross margin was 63.3%, compared with
63.9% for the fiscal year ended January 31, 2023.
- Non-GAAP net loss for the fourth
quarter of fiscal 2024 was $9.8 million, or loss per diluted
ordinary share of $0.24. This compares with non-GAAP net income of
$8.9 million, or earnings per diluted ordinary share of $0.23, for
the same period in fiscal 2023. Non-GAAP net loss for the fiscal
year ended January 31, 2024 was $33.1 million, or loss per diluted
ordinary share of $0.83. This compares with non-GAAP net income of
$43.1 million, or earnings per diluted ordinary share of $1.10, for
the fiscal year ended January 31, 2023.
Based on information available as of today, Ambarella is
offering the following guidance for the first quarter of fiscal
year 2025, ended April 30, 2024:
- Revenue is expected to be between $52.0 million and $56.0
million
- Gross margin on a non-GAAP basis is expected to be between
61.5% and 63.0%
- Non-GAAP operating expenses are expected to be between $46.0
million and $49.0 million
Ambarella reports gross margin, net income (loss) and earnings
(losses) per share in accordance with GAAP and, additionally, on a
non-GAAP basis. Non-GAAP financial information excludes the impact
of stock-based compensation, acquisition-related costs and
restructuring expense adjusted for the associated tax impact, which
includes the effect of recognition or release of valuation
allowances on deferred tax assets. A reconciliation of the GAAP to
non-GAAP gross margin, net income (loss) and earnings (losses) per
share for the periods presented, as well as a description of the
items excluded from the non-GAAP calculations, is included in the
financial statements portion of this press release.
Total cash, cash equivalents and marketable debt securities on
hand at the end of the fourth quarter of fiscal 2024 was $219.9
million, compared with $222.3 million at the end of the prior
quarter and $206.9 million at the end of the same quarter a year
ago.
“We expect to return to revenue growth in fiscal year 2025, due
to the strength of our AI products and the early actions we took to
help our customers navigate their excess inventory. Looking beyond,
we aim to restore growth and profitability while continuing to
drive our edge AI inference R&D focus,” said Fermi Wang,
President and CEO. “In the last year our key achievements included
the continued ramp of our first 5 nanometer AI processor, CV5,
which paves the way for our newer 5nm products. We sampled three
new 5 nanometer AI processors; N1, CV72AQ and CV3-AD685, introduced
our GenAI edge strategy and built-out our CV3 platform with the
ongoing commercialization of our autonomous driving software stack
modules and our centrally processed HD radar perception
software.”
Quarterly Conference Call
Ambarella plans to hold a conference call at 4:30 p.m. Eastern
Time / 1:30 p.m. Pacific Time today with Fermi Wang, President and
Chief Executive Officer, and John Young, Chief Financial Officer,
to discuss the fourth quarter of fiscal year 2024 results. A live
and archived webcast of the call will be available on Ambarella’s
website at http://www.ambarella.com/ for up to 30 days after the
call.
About Ambarella
Ambarella’s products are used in a wide variety of human vision
and edge AI applications, including video security, advanced driver
assistance systems (ADAS), electronic mirror, drive recorder,
driver/cabin monitoring, autonomous driving and robotics
applications. Ambarella’s low-power systems-on-chip (SoCs) offer
high-resolution video compression, advanced image and radar
processing, and powerful deep neural network processing to enable
intelligent perception, fusion and planning. For more information,
please visit www.ambarella.com.
"Safe harbor" statement under the Private Securities
Litigation Reform Act of 1995
This press release contains forward-looking statements that are
not historical facts and often can be identified by terms such as
“outlook,” “projected,” “intends,” “will,” “estimates,”
“anticipates,” “expects,” “believes,” “could,” “should,” or similar
expressions, including the guidance for the first quarter of fiscal
year 2025 ending April 30, 2024, and the comments of our CEO
relating to our expectation of future revenue growth and
longer-term profitability, customer demand for our AI products, our
ability to successfully execute our R&D strategy, and our
ability to commercialize our autonomous driving software stack
modules and our centrally processed HD radar perception software.
The achievement or success of the matters covered by such
forward-looking statements involves risks, uncertainties and
assumptions. Our actual results could differ materially from those
predicted or implied and reported results should not be considered
as an indication of our future performance.
The risks and uncertainties referred to above include, but are
not limited to, global economic and political conditions, including
possible trade tariffs and restrictions; revenue being generated
from new customers or design wins, neither of which is assured; the
commercial success of our customers’ products; our customers’
ability to manage their inventory requirements; our growth
strategy; our ability to anticipate future market demands and
future needs of our customers, particularly for AI computer vision
applications; our ability to introduce, and to generate revenue
from, new and enhanced solutions; our ability to develop, and to
generate revenue from, new advanced technologies, such as computer
vision and AI functionality; our ability to retain and expand
customer relationships and to achieve design wins; the expansion of
our current markets and our ability to successfully enter new
markets, such as the OEM automotive and robotics markets;
anticipated trends and challenges, including competition, in the
markets in which we operate; risks associated with global health
conditions and associated risk mitigation measures; our ability to
effectively manage growth; our ability to retain key employees; and
the potential for intellectual property disputes or other
litigation.
Further information on these and other factors that could affect
our financial results is included in the company’s Quarterly Report
on Form 10-Q for the third quarter of fiscal year 2024, which is on
file with the Securities and Exchange Commission. Additional
information will also set forth in the company’s quarterly reports
on Form 10-Q, annual reports on Form 10-K and other filings the
company makes with the Securities and Exchange Commission from time
to time, copies of which may be obtained by visiting the Investor
Relations portion of our web site at www.ambarella.com or the
SEC's web site at www.sec.gov. Undue reliance should not be placed
on the forward-looking statements in this release, which are based
on information available to us on the date hereof. The results we
report in our Annual Report on Form 10-K for the fiscal year ended
January 31, 2024 could differ from the preliminary results
announced in this press release.
Ambarella assumes no obligation and does not intend to update
the forward-looking statements made in this press release, except
as required by law.
Non-GAAP Financial Measures
The company has provided in this release non-GAAP financial
information, including non-GAAP gross margin, net income (loss),
and earnings (losses) per share, as a supplement to the
consolidated financial statements, which are prepared in accordance
with generally accepted accounting principles ("GAAP"). Non-GAAP
financial information excludes the impact of stock-based
compensation, acquisition-related costs and restructuring expense
adjusted for the associated income tax effect. The income tax
effect adjustment consists of tax effect of items excluded from our
non-GAAP measures, as well as recognition or release of any
valuation allowances on deferred tax assets. A valuation allowance
is a non-cash adjustment primarily reflecting estimates made in
calculation of current and deferred income taxes based on estimated
future taxable profits in the United States, that are not directly
attributable to our consolidated operating performance. Management
uses these non-GAAP financial measures internally in analyzing the
company’s financial results to assess operational performance and
when planning, forecasting and analyzing future periods. Further,
the company believes these non-GAAP financial measures are useful
to investors because they allow for greater transparency with
respect to key financial metrics that the company uses in making
operating decisions and because the company believes that investors
and analysts use them to help assess the health of its business and
for comparison to other companies. The company’s definitions of its
non-GAAP financial measures may differ from the definitions used by
other companies and, therefore, comparability may be limited, and
other companies may not publish these non-GAAP financial measures.
Non-GAAP results are presented for supplemental informational
purposes only for understanding the company’s operating results.
The non-GAAP information should not be considered a substitute for
financial information presented in accordance with GAAP and may be
different from non-GAAP measures used by other companies.
With respect to its financial results for the fourth quarter of
fiscal year 2024, the company has provided below reconciliations of
its non-GAAP financial measures to its most directly comparable
GAAP financial measures. With respect to the company’s expectations
for the first quarter of fiscal year 2025, a reconciliation of the
company’s guidance for non-GAAP gross margin and non-GAAP operating
expenses to the closest corresponding GAAP measure is not available
without unreasonable efforts due to the high variability and low
visibility with respect to the charges excluded from these non-GAAP
measures. We expect the variability of the above charges to have a
significant, and potentially unpredictable, impact on our future
GAAP financial results.
|
AMBARELLA, INC. |
CONSOLIDATED STATEMENTS OF OPERATIONS |
(in thousands, except share and per share
data) |
(unaudited) |
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended January 31, |
|
Twelve Months Ended January 31, |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
|
|
|
Revenue |
|
$ |
51,616 |
|
|
$ |
83,321 |
|
|
$ |
226,474 |
|
|
$ |
337,606 |
|
|
|
|
|
|
|
|
|
|
Cost of revenue |
|
|
20,763 |
|
|
|
33,676 |
|
|
|
89,657 |
|
|
|
128,672 |
|
Gross
profit |
|
|
30,853 |
|
|
|
49,645 |
|
|
|
136,817 |
|
|
|
208,934 |
|
|
|
|
|
|
|
|
|
|
Operating
expenses: |
|
|
|
|
|
|
|
|
Research and development |
|
|
51,992 |
|
|
|
53,054 |
|
|
|
215,052 |
|
|
|
204,946 |
|
Selling, general and administrative |
|
|
20,575 |
|
|
|
20,031 |
|
|
|
76,325 |
|
|
|
78,244 |
|
|
|
|
|
|
|
|
|
|
Total operating
expenses |
|
|
72,567 |
|
|
|
73,085 |
|
|
|
291,377 |
|
|
|
283,190 |
|
|
|
|
|
|
|
|
|
|
Loss from operations |
|
|
(41,714 |
) |
|
|
(23,440 |
) |
|
|
(154,560 |
) |
|
|
(74,256 |
) |
|
|
|
|
|
|
|
|
|
Other income, net |
|
|
2,107 |
|
|
|
1,825 |
|
|
|
6,030 |
|
|
|
3,318 |
|
|
|
|
|
|
|
|
|
|
Loss before income
taxes |
|
|
(39,607 |
) |
|
|
(21,615 |
) |
|
|
(148,530 |
) |
|
|
(70,938 |
) |
|
|
|
|
|
|
|
|
|
Provision (benefit) for income
taxes |
|
|
21,000 |
|
|
|
(10,510 |
) |
|
|
20,887 |
|
|
|
(5,552 |
) |
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(60,607 |
) |
|
$ |
(11,105 |
) |
|
$ |
(169,417 |
) |
|
$ |
(65,386 |
) |
|
|
|
|
|
|
|
|
|
Net loss per share
attributable to ordinary shareholders: |
|
|
|
|
|
|
|
|
Basic |
|
$ |
(1.50 |
) |
|
$ |
(0.29 |
) |
|
$ |
(4.25 |
) |
|
$ |
(1.70 |
) |
Diluted |
|
$ |
(1.50 |
) |
|
$ |
(0.29 |
) |
|
$ |
(4.25 |
) |
|
$ |
(1.70 |
) |
Weighted-average
shares used to compute net loss per share |
|
|
|
|
|
|
|
attributable to ordinary shareholders: |
|
|
|
|
|
|
|
|
Basic |
|
|
40,384,743 |
|
|
|
38,898,290 |
|
|
|
39,878,872 |
|
|
|
38,363,638 |
|
Diluted |
|
|
40,384,743 |
|
|
|
38,898,290 |
|
|
|
39,878,872 |
|
|
|
38,363,638 |
|
|
|
|
|
|
|
|
|
|
The following tables present details of stock-based
compensation, acquisition-related costs and restructuring expense
included in each functional line item in the consolidated
statements of operations above:
|
|
|
|
|
|
|
|
|
Three Months Ended January 31, |
|
Twelve Months Ended January 31, |
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
(unaudited, in thousands) |
Stock-based compensation: |
|
|
|
|
|
|
|
Cost of revenue |
$ |
647 |
|
$ |
2,526 |
|
$ |
3,341 |
|
$ |
3,597 |
Research and development |
|
17,950 |
|
|
17,461 |
|
|
72,759 |
|
|
71,236 |
Selling, general and administrative |
|
9,923 |
|
|
9,120 |
|
|
35,216 |
|
|
36,325 |
|
|
|
|
|
|
|
|
Total stock-based compensation |
$ |
28,520 |
|
$ |
29,107 |
|
$ |
111,316 |
|
$ |
111,158 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended January 31, |
|
Twelve Months Ended January 31, |
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
(unaudited, in thousands) |
Acquisition-related
costs: |
|
|
|
|
|
|
|
Cost of revenue |
$ |
757 |
|
$ |
757 |
|
$ |
3,028 |
|
$ |
3,028 |
Research and development |
|
— |
|
|
— |
|
|
— |
|
|
— |
Selling, general and administrative |
|
520 |
|
|
488 |
|
|
2,080 |
|
|
2,066 |
|
|
|
|
|
|
|
|
Total acquisition-related costs |
$ |
1,277 |
|
$ |
1,245 |
|
$ |
5,108 |
|
$ |
5,094 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended January 31, |
|
Twelve Months Ended January 31, |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
(unaudited, in thousands) |
Restructuring expense: |
|
|
|
|
|
|
|
Cost of revenue |
$ |
— |
|
$ |
— |
|
$ |
66 |
|
$ |
— |
Research and development |
|
36 |
|
|
— |
|
|
708 |
|
|
— |
Selling, general and administrative |
|
68 |
|
|
— |
|
|
182 |
|
|
— |
|
|
|
|
|
|
|
|
Total restructuring expense |
$ |
104 |
|
$ |
— |
|
$ |
956 |
|
$ |
— |
|
|
|
|
|
|
|
|
The difference between GAAP and non-GAAP gross margin was 2.7%
and 3.9%, or $1.4 million and $3.3 million, for the three months
ended January 31, 2024 and 2023, respectively. The difference
between GAAP and non-GAAP gross margin was 2.9% and 2.0%, or $6.4
million and $6.6 million, for the fiscal years ended January 31,
2024 and 2023, respectively. The differences were due to the effect
of stock-based compensation, amortization of acquisition-related
costs and restructuring expense.
AMBARELLA, INC. |
RECONCILIATION OF GAAP TO NON-GAAP DILUTED EARNINGS
(LOSSES) PER SHARE |
(in thousands, except share and per share
data) |
|
|
|
|
|
|
|
|
|
Three Months Ended January 31, |
|
Twelve Months Ended January 31, |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
(unaudited) |
GAAP net loss |
$ |
(60,607 |
) |
|
$ |
(11,105 |
) |
|
$ |
(169,417 |
) |
|
$ |
(65,386 |
) |
|
|
|
|
|
|
|
|
Non-GAAP adjustments: |
|
|
|
|
|
|
|
Stock-based compensation
expense |
|
28,520 |
|
|
|
29,107 |
|
|
|
111,316 |
|
|
|
111,158 |
|
Acquisition-related costs |
|
1,277 |
|
|
|
1,245 |
|
|
|
5,108 |
|
|
|
5,094 |
|
Restructuring expense |
|
104 |
|
|
|
— |
|
|
|
956 |
|
|
|
— |
|
Income tax effect |
|
20,881 |
|
|
|
(10,310 |
) |
|
|
18,971 |
|
|
|
(7,785 |
) |
Non-GAAP net income
(loss) |
$ |
(9,825 |
) |
|
$ |
8,937 |
|
|
$ |
(33,066 |
) |
|
$ |
43,081 |
|
|
|
|
|
|
|
|
|
GAAP - diluted weighted
average shares |
|
40,384,743 |
|
|
|
38,898,290 |
|
|
|
39,878,872 |
|
|
|
38,363,638 |
|
Non-GAAP - diluted weighted
average shares |
|
40,384,743 |
|
|
|
39,639,253 |
|
|
|
39,878,872 |
|
|
|
39,135,313 |
|
|
|
|
|
|
|
|
|
GAAP - diluted net loss per
share |
$ |
(1.50 |
) |
|
$ |
(0.29 |
) |
|
$ |
(4.25 |
) |
|
$ |
(1.70 |
) |
Non-GAAP adjustments: |
|
|
|
|
|
|
|
Stock-based compensation
expense |
|
0.71 |
|
|
|
0.75 |
|
|
|
2.79 |
|
|
|
2.90 |
|
Acquisition-related costs |
|
0.03 |
|
|
|
0.03 |
|
|
|
0.13 |
|
|
|
0.13 |
|
Restructuring expense |
|
— |
|
|
|
— |
|
|
|
0.02 |
|
|
|
— |
|
Income tax effect |
|
0.52 |
|
|
|
(0.27 |
) |
|
|
0.48 |
|
|
|
(0.20 |
) |
Effect of Non-GAAP - diluted
weighted average shares |
|
— |
|
|
|
0.01 |
|
|
|
— |
|
|
|
(0.03 |
) |
Non-GAAP - diluted net income
(loss) per share |
$ |
(0.24 |
) |
|
$ |
0.23 |
|
|
$ |
(0.83 |
) |
|
$ |
1.10 |
|
|
|
|
|
|
|
|
|
During the three months ended January 31, 2024, we recorded a
valuation allowance of $22.7 million on certain deferred tax assets
according to GAAP. Based on current forecasts of future taxable
income in the United States, we believe it is more-likely-than-not
that we will not benefit from these deferred tax assets. This
valuation allowance was excluded from non-GAAP tax expense for the
three and twelve months ended January 31, 2024, and is included in
the “income tax effect” line in the above table.
AMBARELLA, INC. |
CONSOLIDATED BALANCE SHEETS |
(unaudited, in thousands) |
|
|
|
|
|
January 31, |
|
January 31, |
|
|
2024 |
|
|
|
2023 |
|
|
|
|
|
ASSETS |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents |
$ |
144,914 |
|
|
$ |
113,541 |
|
Marketable debt securities |
|
75,013 |
|
|
|
93,322 |
|
Accounts receivable, net |
|
24,950 |
|
|
|
51,987 |
|
Inventories |
|
29,043 |
|
|
|
40,486 |
|
Restricted cash |
|
7 |
|
|
|
8 |
|
Prepaid expenses and other current assets |
|
6,230 |
|
|
|
5,288 |
|
Total current assets |
|
280,157 |
|
|
|
304,632 |
|
|
|
|
|
Property and equipment, net |
|
10,439 |
|
|
|
11,814 |
|
Deferred tax assets, non-current |
|
234 |
|
|
|
19,276 |
|
Intangible assets, net |
|
55,136 |
|
|
|
58,497 |
|
Operating lease right-of-use assets, net |
|
5,250 |
|
|
|
8,339 |
|
Goodwill |
|
303,625 |
|
|
|
303,625 |
|
Other non-current assets |
|
2,814 |
|
|
|
4,012 |
|
|
|
|
|
Total assets |
$ |
657,655 |
|
|
$ |
710,195 |
|
|
|
|
|
LIABILITIES AND
SHAREHOLDERS' EQUITY |
|
|
|
Current liabilities: |
|
|
|
Accounts payable |
|
28,503 |
|
|
|
17,845 |
|
Accrued and other current liabilities |
|
48,598 |
|
|
|
56,655 |
|
Operating lease liabilities, current |
|
3,443 |
|
|
|
3,539 |
|
Income taxes payable |
|
1,541 |
|
|
|
4,112 |
|
Deferred revenue, current |
|
894 |
|
|
|
1,311 |
|
Total current liabilities |
|
82,979 |
|
|
|
83,462 |
|
|
|
|
|
Operating lease liabilities, non-current |
|
1,896 |
|
|
|
5,097 |
|
Other long-term liabilities |
|
12,909 |
|
|
|
15,548 |
|
|
|
|
|
Total liabilities |
|
97,784 |
|
|
|
104,107 |
|
|
|
|
|
Shareholders' equity: |
|
|
|
Preference shares |
|
— |
|
|
|
— |
|
Ordinary shares |
|
18 |
|
|
|
18 |
|
Additional paid-in capital |
|
694,967 |
|
|
|
572,076 |
|
Accumulated other comprehensive loss |
|
(183 |
) |
|
|
(492 |
) |
Retained earnings (accumulated deficit) |
|
(134,931 |
) |
|
|
34,486 |
|
Total shareholders’ equity |
|
559,871 |
|
|
|
606,088 |
|
|
|
|
|
Total liabilities and shareholders' equity |
$ |
657,655 |
|
|
$ |
710,195 |
|
|
|
|
|
Contact:
Louis Gerhardy408.636.2310lgerhardy@ambarella.com
Ambarella (NASDAQ:AMBA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ambarella (NASDAQ:AMBA)
Historical Stock Chart
From Apr 2023 to Apr 2024